H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating.
Share this article
Corporate
Score 35
Neutral
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating
Mar 11, 2026 21:38 UTC
CORT
Short term
Related Articles
Score 65
Bullish
Why CoreWeave Stock Surged Higher This Week
Mar 14, 15:55
Score 75
Bullish
Jensen Huang Says the "Agentic AI Inflection Point Has Arrived." Here Are 2 Stocks to Buy for 2026.
Mar 14, 15:25
Score 35
Jim Cramer Says Food Companies Need to Consolidate and Kraft Heinz CEO Steve Cahillane Should Be the One to Do It
Mar 14, 14:41
Score 25
Bearish
Jim Cramer Says “Conagra’s Been a Nightmare of a Stock”
Mar 14, 14:41
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.